Globapharm is pleased to announce its agency agreement for Energast, a new product for the treatment of IBS in Australia, with Bioton S.A, a Poland based innovative biotech organisation.
Globapharm is pleased to announce its agency agreement for Energast, a new product for the treatment of IBS in Australia, with Bioton S.A, a Poland based innovative biotech organisation.